BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,217 | -62.0% | 22,220 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $147,985 | -98.0% | 22,220 | -94.3% | 0.00% | -98.0% |
| Q1 2023 | $7,254,355 | -33.2% | 388,765 | -23.2% | 0.10% | -37.0% |
| Q4 2022 | $10,867,462 | +1989.9% | 505,934 | +4116.1% | 0.16% | +1372.7% |
| Q3 2020 | $520,000 | -96.5% | 12,000 | -95.8% | 0.01% | -97.0% |
| Q2 2020 | $15,016,000 | +124.0% | 283,264 | -5.6% | 0.36% | +62.9% |
| Q1 2020 | $6,703,000 | – | 299,932 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |